Selecta Biosciences' IPO

Selecta Biosciences raised a round of funding on June 22, 2016. Investors include Public.

Selecta Biosciences is a biopharmaceutical company developing a new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic a…

Articles about Selecta Biosciences' IPO: